Evidence map›Paper›PMID 20233725›Full record

ArticleThe Journal of biological chemistry2010

Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress.

Michael G Kemp, Zafer Akan, Seçil Yilmaz, Mary Grillo, Stephanie L Smith-Roe, Tae-Hong Kang, Marila Cordeiro-Stone, William K Kaufmann, Robert T Abraham, Aziz Sancar and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. The TIMELESS effort for timely DNA replication and protection.Cellular and molecular life sciences : CMLS · 2023
    Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Michael G KempDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.
Zafer Akan
Seçil Yilmaz
Mary Grillo
Stephanie L Smith-Roe
Tae-Hong Kang
Marila Cordeiro-Stone
William K Kaufmann
Robert T Abraham
Aziz Sancar
Keziban Unsal-Kaçmaz
University of North Carolina at Chapel Hill · USPfizer (United States) · USUNC Lineberger Comprehensive Cancer Center

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
STRUCTURE AND FUNCTION OF UVRABC EXCISION NUCLEASER01GM032833 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SANCAR, AZIZ · 1985 to 2015
$8.9M
The System of Response to DNA Damage Suppresses Environmental MelanomagenesisP01ES014635 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMANN, WILLIAM K. · 2007 to 2011
$6.7M
ENVIRONMENTAL PATHOLOGYT32ES007017 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAUFMAN, DAVID G. · 1985 to 2011
$5.1M
Cellular Responses to Environmental Insults and Risk for Melanoma DevelopmentR01ES015856 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CORDEIRO-STONE, MARILA · 2007 to 2011
$1.2M
NCI NIH HHS T32 CA009156NCI NIH HHS T32-CA09156NIEHS NIH HHS ES014635NIEHS NIH HHS ES015856NIEHS NIH HHS P01 ES014635NIEHS NIH HHS P30 ES010126NIEHS NIH HHS R01 ES015856NIEHS NIH HHS T32 ES007017NIEHS NIH HHS T32-ES07017NIGMS NIH HHS GM32833NIGMS NIH HHS R01 GM032833
6 · The paper itself

Abstract

Mammalian Timeless is a multifunctional protein that performs essential roles in the circadian clock, chromosome cohesion, DNA replication fork protection, and DNA replication/DNA damage checkpoint pathways. The human Timeless exists in a tight complex with a smaller protein called Tipin (Timeless-interacting protein). Here we investigated the mechanism by which the Timeless-Tipin complex functions as a mediator in the ATR-Chk1 DNA damage checkpoint pathway. We find that the Timeless-Tipin complex specifically mediates Chk1 phosphorylation by ATR in response to DNA damage and replication stress through interaction of Tipin with the 34-kDa subunit of replication protein A (RPA). The Tipin-RPA interaction stabilizes Timeless-Tipin and Tipin-Claspin complexes on RPA-coated ssDNA and in doing so promotes Claspin-mediated phosphorylation of Chk1 by ATR. Our results therefore indicate that RPA-covered ssDNA not only supports recruitment and activation of ATR but also, through Tipin and Claspin, it plays an important role in the action of ATR on its critical downstream target Chk1.

Indexed as

Gene Expression RegulationAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell CycleCell Cycle ProteinsCell LineCell NucleusCheckpoint Kinase 1DimerizationDNA-Binding ProteinsDNA, Single-StrandedHeLa CellsHumansModels, BiologicalNuclear ProteinsAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanCLSPN protein, humanDNA-Binding ProteinsDNA, Single-StrandedNuclear ProteinsProtein KinasesProtein Serine-Threonine KinasesReplication Protein ATipin protein, human

Identifiers

PMID20233725
PMCPMC2878033
OpenAlexW2067063718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.